Client News

AiCuris Received 15 Million Euros Milestone Payment from Licensing Partner MSD Following EMA Approval of PREVYMIS® for Prevention of CMV Infection in High-Risk Adult Kidney Transplant Recipients

InflaRx Announces Positive Topline Results from the Multiple Ascending Dose (MAD) Phase I Study with C5aR Inhibitor INF904

Abivax 2024 Financial Communication Calendar

Newron reports exceptional one-year results of study 014/15 with evenamide in treatment-resistant schizophrenia (TRS)

Newron completes enrollment of schizophrenia patients in potentially pivotal study 008A with Evenamide

CARBIOS publishes its second sustainability report and confirms its ambitions to accelerate the circular economy for plastic

invIOs to attend JP Morgan Week in San Francisco in January

CARBIOS has received €1.2M of the €11.4M granted by ADEME to further optimize its unique PET depolymerization process and guarantee its competitiveness

iOmx Therapeutics attends 2024 J.P. Morgan Healthcare Conference

Lindis Blood Care Announces Last Patient Out in Multicenter Clinical Certification Study REMOVE with CATUVAB® to Eliminate Tumor Cells from Surgical Blood